text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

Precursor of the Chiral Hypervalent Iodine Catalyst

(R,R)-2-Iodo-1,3-bis[1-(mesitylcarbamoyl)ethoxy]benzene (1), which was developed by Ishihara et al., is a precursor of the chiral hypervalent iodine catalyst, and its utility for the enantioselective intramolecular oxidative coupling reaction (Kita Spirolactonization) has been reported. The chiral hypervalent iodine(III) species, which is generated in situ from 1 and mCPBA as a co-oxidant, catalyzes the enantioselective spirolactonization of 1-naphthol derivatives 2 to afford the corresponding spirolactones 3 with high enantioselectivities. This reaction is environmentally benign because it does not have to use any toxic metal reagents. Since spirolactones are used as pharmaceutical intermediates, it is expected to be applied to pharmaceutical synthesis.
Typical Procedure1b) :
A solution of 2a (R=H) (216 mg, 1.0 mmol), 1 (92.2 mg, 0.15 mmol, 15 mol%) and mCPBA (269 mg, 1.2 mmol, 1.2 eq.) in CHCl3 (50 mL) is stirred at 0 °C. After 18 h, the resulting mixture is poured into aqueous Na2S2O3 (20 mL) and aqueous NaHCO3, and extracted with CHCl3 (2 times). The organic layers are dried over anhydrous MgSO4 and solvents are removed in vacuo. The residue is purified by flash column chromatography on silica gel (hexane-EtOAc = 10:1 to 4:1) to give 3a (129 mg, 0.6 mmol) in 60% yield (92%ee).

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.